Evidence map›Paper›PMID 39686350›Full record

ArticleSensors (Basel, Switzerland)2024

Performance of a Non-Invasive System for Monitoring Blood Glucose Levels Based on Near-Infrared Spectroscopy Technology (

Fernando Gómez-Peralta, Luis Gabriel Luque Romero, Antonio Puppo-Moreno, Jesús Riesgo

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fernando Gómez-PeraltaEndocrinology and Nutrition Unit, Segovia General Hospital, Luis Erik Clavería Neurólogo S.N Street, 40002 Segovia, Spain.ORCID 0000-0003-0106-0091
Luis Gabriel Luque RomeroHealth Care Center La Algaba, 41980 La Algaba, Spain.
Antonio Puppo-MorenoIntensive Care Unit, Hospital Universitario Virgen Del Rocío, Avda. Manuel Siurot, s/n, 41013 Seville, Spain.
Jesús RiesgoGLUCUBE, 41011 Seville, Spain.

Funding

IGLUCO TECH, S.L., Seville, Spain DIA-2021-01
6 · The paper itself

Abstract

backgroundThe need for frequent blood glucose (BG) monitoring and the inconveniences associated with self-monitoring of BG (SMBG) have driven the development of non-invasive approaches.

methodsThis prospective study aimed to investigate the accuracy of glucose level calculation using the near-infrared spectroscopy (NIRS) technology

resultsOverall, 105 subjects (mean age 53.8 ± 13.8 years, 50.5% female) participated, resulting in 1914 paired glucose measurements between 49 and 331 mg/dL. Total mean absolute relative difference (MARD) was 20.3%, MARD for values >100 mg/dL was 18.3%, and mean absolute deviation (MAD) for values <100 mg/dL was 24.9%. A total of 97.3% of measurements fell within A+B Parkes zones, and 58.8%, 76.9%, and 88.1% within +-20%, +-30%, or +-40% error, respectively. On completion, 62 participants (59%) fulfilled the one-week prospective sub-study. In this subgroup, the total MARD was reduced between day 1 and day 8 from 22.8 to 18.3% (

conclusions

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 2Spectroscopy, Near-InfraredAdultAgedDiabetes Mellitus, Type 1FemaleHumansMaleMiddle AgedProspective StudiesBlood GlucoseadherencediabetesGlucube®non-invasive glucose monitoringself management

Identifiers

PMID39686350
PMCPMC11645037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.